Literature DB >> 9101425

Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models.

G M Wilson1, E A Roberts, R G Deeley.   

Abstract

In the human hepatocarcinoma cell lines HepG2 and Hep3B, low density lipoprotein receptor (LDLR) mRNA levels were rapidly and transiently induced after treatment with phorbol-12-myristate-13-acetate (PMA), increasing by approximately 50-fold and 8-fold, respectively, within 4 h before returning to near basal levels by 24 h. The difference in magnitude of mRNA accumulation between these cell lines is at least partly due to a rapid 2- to 2.5-fold stabilization of LDLR mRNA in HepG2 cells after PMA treatment. Stabilization of LDLR mRNA in response to PMA was also observed in HH01 cells, a human hepatocyte coculture system derived from normal human liver. In both HepG2 and HH01 cells, PMA treatment induced a rapid morphological change with characteristics of cytoskeletal reorganization. The changes in morphology and stabilization of LDLR mRNA by PMA were coincident in the cell lines tested and were independent of de novo gene expression. Subcellular fractionation studies indicated that LDLR polysomes may be associated with the cytoskeleton in HepG2 cells. Disruption of the action cytoskeleton but not microtubules abrogated stabilization of LDLR mRNA by PMA. These data suggest that components of the actin cytoskeleton are involved in the regulated decay of LDLR mRNA in some human liver cell culture systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101425

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division.

Authors:  J S Arthur; J S Elce; C Hegadorn; K Williams; P A Greer
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Regulation of AUF1 expression via conserved alternatively spliced elements in the 3' untranslated region.

Authors:  G M Wilson; Y Sun; J Sellers; H Lu; N Penkar; G Dillard; G Brewer
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 3.  Human low-density lipoprotein receptor gene and its regulation.

Authors:  Wei-Jia Kong; Jingwen Liu; Jian-Dong Jiang
Journal:  J Mol Med (Berl)       Date:  2005-11-16       Impact factor: 4.599

4.  A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression.

Authors:  Amar Bahadur Singh; Chin Fung Kelvin Kan; Vikram Shende; Bin Dong; Jingwen Liu
Journal:  J Lipid Res       Date:  2014-05-02       Impact factor: 5.922

5.  The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue.

Authors:  Amar Bahadur Singh; Hai Li; Chin Fung Kelvin Kan; Bin Dong; Mark R Nicolls; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-24       Impact factor: 8.311

6.  Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements.

Authors:  Hai Li; Wei Chen; Yue Zhou; Parveen Abidi; Orr Sharpe; William H Robinson; Fredric B Kraemer; Jingwen Liu
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

7.  The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells.

Authors:  Brian Morin; LaNita A Nichols; Katherine M Zalasky; J Wade Davis; John A Manthey; Lené J Holland
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

8.  Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.

Authors:  Amar Bahadur Singh; Bin Dong; Fredric B Kraemer; Yanyong Xu; Yanqiao Zhang; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

9.  Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.

Authors:  Guo-Hua Qiu; Xiaojin Xie; Fang Xu; Xiaohao Shi; Yue Wang; Linhong Deng
Journal:  Cytotechnology       Date:  2014-07-08       Impact factor: 2.058

10.  Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells.

Authors:  Noelle B Vargas; Brandy Y Brewer; Terry B Rogers; Gerald M Wilson
Journal:  J Lipid Res       Date:  2008-10-20       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.